Key result
Leonurine improved inflammation, oxidative stress, and obesity-induced vascular dysfunction in an obese mouse model by targeting YTHDF1.
Why the study?
Oxidative stress in adipose tissue is a crucial mechanism of obesity-associated cardiovascular diseases, and it was unknown whether leonurine alleviates inflammation, oxidative stress, and vascular dysfunction in obesity.
Does Leonurine improve vascular dysfunction and inflammation in an obese mouse model?
Does Leonurine improve vascular dysfunction and inflammation in an obese mouse model?
Leonurine improves obesity-induced oxidative stress and vascular remodeling by targeting YTHDF1 in preclinical models, suggesting potential for treating obesity-related metabolic syndromes.
Leonurine may protect against obesity-related vascular dysfunction in mice; hypothesis-generating for human translation.
Oxidative stress in adipose tissue is a crucial pathogenic mechanism of obesity-associated cardiovascular diseases. Chronic low-grade inflammation caused by obesity increases ROS production and dysregulation of adipocytokines. Leonurine (LEO) is an active alkaloid extracted from Herba Leonuri and plays a protective role in the cardiovascular system. The present study tested whether LEO alleviates inflammation and oxidative stress, and improves vascular function in an obese mouse model. Here, we found that obesity leads to inflammation and oxidative stress in epididymal white adipose tissue (EWAT), as well as vascular dysfunction. LEO significantly improved inflammation and oxidative stress both in vivo and in vitro. Obesity-induced vascular dysfunction was also improved by LEO as evidenced by the ameliorated vascular tone and decreased mesenteric artery fibrosis. Using mass spectrometry, we identified YTHDF1 as the direct target of LEO. Taken together, we demonstrated that LEO improves oxidative stress and vascular remodeling induced by obesity and targets YTHDF1, raising the possibility of LEO treating other obesity-related metabolic syndromes.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2022) studied Obesity-related vascular dysfunction and inflammation. Leonurine (LEO) was evaluated on Inflammation, oxidative stress, and vascular function. Leonurine improved inflammation, oxidative stress, and obesity-induced vascular dysfunction in an obese mouse model by targeting YTHDF1.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: